
    
      Delta-tocotrienol is a natural Vitamin E compound that has been consumed by humans as a
      dietary supplement. The Food and Drug Administration (FDA) has not approved it for sale as a
      drug. Vitamin E Delta-tocotrienol is being investigated for the prevention and treatment of
      pancreatic tumors. The usefulness of the Vitamin E Delta-tocotrienol in treating human tumors
      is unknown.

      This study consists of the following: (1) a Pre-Treatment Period in which participants are
      consented and qualified for the study; (2) a Study Treatment Period in which participant will
      receive Vitamin E δ-Tocotrienol administered orally twice daily for 14 (±2) consecutive days
      and once on the day of surgery, with associated pharmacokinetic and pharmacodynamic sampling;
      (3) a Post Treatment Period in which laboratory and physical examinations are performed.
      Adverse events will be recorded throughout the study.
    
  